FXNCX
Price
$10.09
Change
+$0.04 (+0.40%)
Updated
Apr 24 closing price
Net Assets
568.32M
MPRAX
Price
$8.67
Change
+$0.05 (+0.58%)
Updated
Apr 24 closing price
Net Assets
141.5M
Ad is loading...

FXNCX vs MPRAX

Header iconFXNCX vs MPRAX Comparison
Open Charts FXNCX vs MPRAXBanner chart's image
Franklin NC Tax-Free Income A1
Price$10.09
Change+$0.04 (+0.40%)
VolumeN/A
Net Assets568.32M
MFS AR Municipal Bond R6
Price$8.67
Change+$0.05 (+0.58%)
VolumeN/A
Net Assets141.5M
FXNCX vs MPRAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FXNCX vs. MPRAX commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXNCX is a Hold and MPRAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
FXNCX has more cash in the bank: 568M vs. MPRAX (141M). MPRAX pays higher dividends than FXNCX: MPRAX (3.45) vs FXNCX (2.87). FXNCX was incepted earlier than MPRAX: FXNCX (38 years) vs MPRAX (8 years). FXNCX (0.70) is less costly to investors than MPRAX (0.62). MPRAX is a more actively managed with annual turnover of: 16.00 vs. FXNCX (14.73). MPRAX has a lower initial minimum investment than FXNCX: MPRAX (0) vs FXNCX (1000). MPRAX annual gain was more profitable for investors over the last year : 0.20 vs. FXNCX (-0.22). MPRAX return over 5 years is better than : 3.66 vs. FXNCX (-4.45).
FXNCXMPRAXFXNCX / MPRAX
Total Expense Ratio0.700.53132%
Annual Report Gross Expense Ratio0.700.62113%
Fund Existence38 years8 years-
Gain YTD-3.252-3.180102%
Front Load4%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets568M141M403%
Annual Yield % from dividends2.873.4583%
Returns for 1 year-0.220.20-110%
Returns for 3 years1.162.8640%
Returns for 5 years-4.453.66-122%
Returns for 10 years-7.16N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FPHAX23.40N/A
N/A
Fidelity Select Pharmaceuticals Port
MCSPX10.28N/A
N/A
BlackRock Advantage SMID Cap Inv C
MCGAX8.73N/A
N/A
Transamerica Mid Cap Growth A
RYYCX136.17N/A
N/A
Rydex S&P SmallCap 600 Pure Value C
VVOSX19.68N/A
N/A
Invesco Value Opportunities R6